Acute lung injury: a yellow card for engineered nanoparticles?
Application of nanomaterials in various diagnostic and therapeutic areas shows great promise. To translate nanotechnology into nanomedicine, it is important to understand any potential mechanisms of toxicity caused by nanomaterials, and to design approaches to mitigate any detrimental effects.
Liu
Mingyao
M
Toronto General Research Institute, University Health Network, Toronto, ON, Canada. mingyao.liu@utoronto.ca
Zhang
Haibo
H
Slutsky
Arthur S
AS
D055371:Acute Lung Injury / Q000139:chemically induced*; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D050091:Dendrimers; D006801:Humans; D050997:Nanomedicine / Q000379:methods*; D053758:Nanoparticles / Q000737:chemistry* / Q000633:toxicity; D011073:Polyamines / Q000633:toxicity
D050091:Dendrimers; C104700:PAMAM Starburst; D011073:Polyamines